Sci-Tech Montana: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Montana.

Press releases published on October 1, 2026

Oct. 1, 2026

Arbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer

Indeterminate GlobeNewswire

Oct. 1, 2026

InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development

Indeterminate GlobeNewswire

Oct. 1, 2026

Galimedix Therapeutics presents baseline data from Phase 2 eDREAM trial highlighting patient-tailored microperimetry as a sensitive and precise functional measurement in geographic atrophy studies

Indeterminate GlobeNewswire

Oct. 1, 2026

Calian completes sale of U.S. commercial IT business to Trace3

Indeterminate GlobeNewswire

Oct. 1, 2026

Lantronix Secures Blue UAS Companion Computer SOM Listing, Expanding Defense Drone Opportunity

Indeterminate GlobeNewswire

Oct. 1, 2026

Caspian Therapeutics Appoints Manasi Jaiman, M.D., M.P.H., and Elizabeth Mily to Board of Directors

Indeterminate GlobeNewswire

Oct. 1, 2026

Templafy Report Finds 95% of Knowledge Workers Edit AI-Generated Documents Before They’re Business-Ready

Indeterminate GlobeNewswire

Oct. 1, 2026

MitoRx Therapeutics presents new preclinical data on MTRX31, demonstrating restored mitochondrial density, at the 62nd EASD Annual Meeting

Indeterminate GlobeNewswire

Oct. 1, 2026

Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences

Indeterminate GlobeNewswire

Oct. 1, 2026

Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD Risk

Indeterminate GlobeNewswire

Oct. 1, 2026

Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities

Indeterminate GlobeNewswire

Oct. 1, 2026

Shattuck Labs Announces Phase 2 Clinical Trial of SL-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.D., as Senior Vice President, Clinical Development

Indeterminate GlobeNewswire

Oct. 1, 2026

Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences

Indeterminate GlobeNewswire

Oct. 1, 2026

Kyntra Bio Appoints Andrew E. Singer, MBA to its Board of Directors

Indeterminate GlobeNewswire

Oct. 1, 2026

Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer

Indeterminate GlobeNewswire

Oct. 1, 2026

Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer

Indeterminate GlobeNewswire

Oct. 1, 2026

Manifests Ireland Grows Customs Operations from 20,000 to 2 Million Annual Declarations with Descartes Customs Compliance Solution

Indeterminate GlobeNewswire

Oct. 1, 2026

Kailera Therapeutics Presents New Clinical Data at EASD 2026 Annual Meeting

Indeterminate GlobeNewswire

Oct. 1, 2026

Agomab Reports Positive Topline Data from STENOVA Open-Label Extension Study of Ontunisertib in Fibrostenosing Crohn's Disease

Indeterminate GlobeNewswire

Oct. 1, 2026

Nxera Announces Successful Resolution of miniG Patent Infringement Action

Indeterminate GlobeNewswire